![Katja Rosenkranz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Katja Rosenkranz
Director/Miembro de la Junta en Dualyx NV .
Cargos activos de Katja Rosenkranz
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
V-Bio Ventures BV
![]() V-Bio Ventures BV Investment ManagersFinance V-Bio Ventures BV is an Independent Venture Capital firm founded in 2015 by Christina Takke and Willem Broekaert. V-Bio Ventures BV is headquartered in Ghent. | Inversor de Capital Privado | 01/01/2016 | - |
Dualyx NV
![]() Dualyx NV Miscellaneous Commercial ServicesCommercial Services Dualyx NV is a biotech company based in Ghent, Belgium that focuses on developing novel Treg-based therapies for patients with difficult-to-treat autoimmune diseases. The CEO of the company is Wouter Verhoeven, and it is located in Zwijnaarde, Belgium. Dualyx has developed a pipeline of highly promising immune modulating programs, including DT-001, an antibody agonist program targeting the TNF receptor 2 (TNFR2), which is currently in IND-enabling studies. The Belgian company aims to create next-generation biologic drugs for autoimmunity therapies with novel mechanisms of action, lower toxicity, and improved patient outcomes than traditional therapeutics. The company was founded in 2020 by Luc van Rompaey in collaboration with Wurzburg University, Argenx, VIB, Ghent University, and KU Leuven. | Director/Miembro de la Junta | 31/05/2020 | - |
Historial de carrera de Katja Rosenkranz
Antiguos cargos conocidos de Katja Rosenkranz.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Clearstream Banking AG
![]() Clearstream Banking AG Regional BanksFinance Clearstream Banking AG engages in providing commercial banking services. Its services include settlement, custody, global securities, financing, investment fund, business and IT solutions and customer support. The company is headquartered in Eschborn, Germany. | Corporate Officer/Principal | 01/01/2003 | 31/03/2012 |
AgomAb Therapeutics NV
![]() AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Director/Miembro de la Junta | - | - |
Advitos GmbH
![]() Advitos GmbH Medical SpecialtiesHealth Technology Advitos GmbH manufactures, develops, and markets liver support therapy devices. Its therapy device helps enhance the survival of patients with life-threatening liver diseases. The company was founded by Dr. Bernhard Kreyman in 2005 and is headquartered in Munich, Germany. | Director Administrativo | 02/12/2009 | 14/06/2012 |
Director de Operaciones | 02/12/2009 | 14/06/2012 | |
Director Financiero/CFO | 02/12/2009 | 14/06/2012 | |
Corporate Officer/Principal | 02/12/2009 | - |
Estadísticas
Internacional
Bélgica | 4 |
Alemania | 3 |
Operativa
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Chief Administrative Officer | 1 |
Sectorial
Finance | 3 |
Commercial Services | 3 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 5 |
---|---|
Clearstream Banking AG
![]() Clearstream Banking AG Regional BanksFinance Clearstream Banking AG engages in providing commercial banking services. Its services include settlement, custody, global securities, financing, investment fund, business and IT solutions and customer support. The company is headquartered in Eschborn, Germany. | Finance |
Advitos GmbH
![]() Advitos GmbH Medical SpecialtiesHealth Technology Advitos GmbH manufactures, develops, and markets liver support therapy devices. Its therapy device helps enhance the survival of patients with life-threatening liver diseases. The company was founded by Dr. Bernhard Kreyman in 2005 and is headquartered in Munich, Germany. | Health Technology |
V-Bio Ventures BV
![]() V-Bio Ventures BV Investment ManagersFinance V-Bio Ventures BV is an Independent Venture Capital firm founded in 2015 by Christina Takke and Willem Broekaert. V-Bio Ventures BV is headquartered in Ghent. | Finance |
AgomAb Therapeutics NV
![]() AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Commercial Services |
Dualyx NV
![]() Dualyx NV Miscellaneous Commercial ServicesCommercial Services Dualyx NV is a biotech company based in Ghent, Belgium that focuses on developing novel Treg-based therapies for patients with difficult-to-treat autoimmune diseases. The CEO of the company is Wouter Verhoeven, and it is located in Zwijnaarde, Belgium. Dualyx has developed a pipeline of highly promising immune modulating programs, including DT-001, an antibody agonist program targeting the TNF receptor 2 (TNFR2), which is currently in IND-enabling studies. The Belgian company aims to create next-generation biologic drugs for autoimmunity therapies with novel mechanisms of action, lower toxicity, and improved patient outcomes than traditional therapeutics. The company was founded in 2020 by Luc van Rompaey in collaboration with Wurzburg University, Argenx, VIB, Ghent University, and KU Leuven. | Commercial Services |
- Bolsa de valores
- Insiders
- Katja Rosenkranz
- Experiencia